SF3B1 mutations in AML are strongly associated with MECOM rearrangements and may be indicative of an MDS pre-phase

Sandra Huber, Torsten Haferlach, Manja Meggendorfer, Stephan Hütter, Gregor Hoermann, Constance Baer, Wolfgang Kern, Claudia Haferlach